J Cavanaugh1, K Viney2,3, T Kienene4, D Harley3, P M Kelly5,6, A Sleigh3, J O'Connor7, S Mase1. 1. Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA. 2. Public Health Division, Secretariat of the Pacific Community, Noumea, New Caledonia. 3. National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia. 4. National TB Program, Ministry of Health and Medical Services, Tarawa, Kiribati. 5. Population Health Division, ACT Government Health Directorate, Canberra, ACT, Australia. 6. Australian National University Medical School, Canberra, ACT, Australia. 7. Public Health Consultant, Auckland, New Zealand.
Abstract
OBJECTIVES: To determine the association between diabetes and the clinical features and treatment outcomes of TB in Kiribati. METHODS: We enrolled consecutive patients with TB who presented from August 2010 to February 2012 and compared clinical features and TB treatment outcomes for patients with and without diabetes, as measured by haemoglobin A1c assay. Poor outcome was defined as death, default or treatment failure, and good outcome as treatment success or cure. RESULTS: Two hundred and seventy-five eligible persons with TB disease were enrolled; 101 (37%) had diabetes. TB patients with diabetes were more likely to have acid-fast bacilli (AFB) seen on sputum smear microscopy (RR: 1.3; 95% CI: 1.03-1.62). The risk of poor outcome did not differ between patients with or without diabetes (RR: 1.1; 95% CI: 0.5-2.7). CONCLUSION: TB patients with diabetes are more likely than those without to have sputum with AFB on microscopy. This could increase transmission in the community. Early detection of TB by screening patients with diabetes, and the converse, could be important public health interventions where diabetes and TB are prevalent.
OBJECTIVES: To determine the association between diabetes and the clinical features and treatment outcomes of TB in Kiribati. METHODS: We enrolled consecutive patients with TB who presented from August 2010 to February 2012 and compared clinical features and TB treatment outcomes for patients with and without diabetes, as measured by haemoglobin A1c assay. Poor outcome was defined as death, default or treatment failure, and good outcome as treatment success or cure. RESULTS: Two hundred and seventy-five eligible persons with TB disease were enrolled; 101 (37%) had diabetes. TBpatients with diabetes were more likely to have acid-fast bacilli (AFB) seen on sputum smear microscopy (RR: 1.3; 95% CI: 1.03-1.62). The risk of poor outcome did not differ between patients with or without diabetes (RR: 1.1; 95% CI: 0.5-2.7). CONCLUSION:TBpatients with diabetes are more likely than those without to have sputum with AFB on microscopy. This could increase transmission in the community. Early detection of TB by screening patients with diabetes, and the converse, could be important public health interventions where diabetes and TB are prevalent.
Authors: Mario Raviglione; Ben Marais; Katherine Floyd; Knut Lönnroth; Haileyesus Getahun; Giovanni B Migliori; Anthony D Harries; Paul Nunn; Christian Lienhardt; Steve Graham; Jeremiah Chakaya; Karin Weyer; Stewart Cole; Stefan H E Kaufmann; Alimuddin Zumla Journal: Lancet Date: 2012-05-19 Impact factor: 79.321
Authors: S W Park; J W Shin; J Y Kim; I W Park; B W Choi; J C Choi; Y S Kim Journal: Eur J Clin Microbiol Infect Dis Date: 2011-10-25 Impact factor: 3.267
Authors: Christie Y Jeon; Anthony D Harries; Meghan A Baker; Jessica E Hart; Anil Kapur; Knut Lönnroth; Salah-Eddine Ottmani; Sunali Goonesekera; Megan B Murray Journal: Trop Med Int Health Date: 2010-09-24 Impact factor: 2.622
Authors: K Kranzer; H Afnan-Holmes; K Tomlin; J E Golub; A E Shapiro; A Schaap; E L Corbett; K Lönnroth; J R Glynn Journal: Int J Tuberc Lung Dis Date: 2013-04 Impact factor: 2.373
Authors: Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati Journal: Lancet Date: 2011-06-24 Impact factor: 79.321
Authors: Barbara Reis-Santos; Rodrigo Locatelli; Bernardo L Horta; Eduardo Faerstein; Mauro N Sanchez; Lee W Riley; Ethel Leonor Maciel Journal: PLoS One Date: 2013-04-24 Impact factor: 3.240
Authors: Siti Rohana Ahmad; Nor Azwany Yaacob; Mat Zuki Jaeb; Zalmizy Hussin; Wan Mohd Zahiruddin Wan Mohammad Journal: Iran J Public Health Date: 2020-08 Impact factor: 1.429
Authors: R M Trinidad; R Brostrom; M I Morello; D Montgomery; C C Thein; M L Gajitos; A Heetderks; T Chorba Journal: J Clin Tuberc Other Mycobact Dis Date: 2016-10-22